Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS
Emmanuelle Waubant(University of California, San Francisco), D Goodkin(The Stables), Richard A. Rudick(Norwalk Hospital), R. Sloan(The Stables), Lauren Gee(University of California, San Francisco), Anne Cotleur(Cleveland Clinic), Peter Bacchetti(University of California, San Francisco)
Cited by 63
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Age Affects Outcomes in Chronic Kidney Disease
|Journal of the American Society of Nephrology|2007|749